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Introduction
The 5/6 nephrectomy (5/6 NE) is a well established model 
of progressive renal injury that is characterized by sys-
temic hypertension, loss of renal function, proteinuria and 
histological changes, similar to those observed in many 
human renal diseases.1,2 The increase in Angiotensin II 
(AII) production by the remaining kidney contributes to 
the development of glomerular hypertension and hypertro-
phy, resulting in progressive renal damage.3 Hypertrophy 
and glomerular hypertension stretch the epithelial glomer-
ular cells, resulting in severe loss of podocytes in the urine 
and proteinuria.4 The leakage of proteins into tubular fluid 
provokes interstitial inflammation that aggravates renal 
lesions.5,6 Proteins can stimulate proximal tubular cells to 
synthesize chemokines, such as monocyte chemoattractant 
protein-1 (MCP-1), which recruit monocytes and mac-
rophages.7 The monocyte/macrophage inflammatory cells 
can produce AII, which also plays an important role in 
both inflammation and in renal hemodynamic changes.4 
AII is a potent inducer of transforming growth factor-β 
(TGF-β) and platelet-derived growth factor (PDGF), and 
these cytokines mediate some of the AII effects.8,9 TGF-β, 
one of the major fibrogenic cytokines, enhances the syn-
thesis of matrix components and blocks matrix degrada-
tion, thereby promoting extracellular matrix (ECM) 
accumulation.8,10 TGF-β and AII can induce phenotypic 
modification in cells, causing them to express α-smooth 
muscle actin and increase the production of collagen and 
other ECM components. AII can also activate nuclear 
factor-кB (NF-кB) and mitogen-activated protein kinases 
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(MAPK).11,12 The MAPK c-Jun N-terminal kinase (JNK) 
and NF-кB have been implicated in apoptosis, inflamma-
tion and the synthesis of inflammatory mediators. The 
renoprotection by antagonists of AII has been extensively 
demonstrated in models of nephropathies and in prospec-
tive controlled trials in patients with kidney disease.13–15
Cecropia pachystachya (CP) is a plant that grows in the 
rainforests of South America and is popularly known in 
Brazil as embauba. The plants that belong to the genus of 
Cecropia are traditionally used in several Latin American 
countries to treat hypertension, and pulmonary and cardiac 
disease.16 CP extract is a rich source of polyphenols, 
mainly flavonoids, that have antioxidant and anti-inflam-
matory activities. 17–19 The antihypertensive and cardio-
vascular protective effects of flavonoids and procyanidins 
present in food were associated with angiotensin convert-
ing enzyme (ACE) inhibition.20,21 Polyphenols isolated 
from CP leaf extract such as orientin, isoorientin, isovi-
texin, isoquercitrin and procyanidins, can provoke ACE 
inhibition in vitro.22 However, studies of the effect of CP 
extract on the progression of kidney disease have not been 
performed yet. Therefore, the aim of our study was to eval-
uate the effect of CP extract on renal injury provoked by 
5/6 NE.
Materials and methods
Animals and experimental protocols
A total of 44 male Wistar rats (180–200 g) were used in 
this study. The animals were maintained in a total of four 
animals per cage at a temperature of 22°C with a light-dark 
cycle of 12 h and fed with standard diet ad libitum. The 
experiments were performed in accordance with the ethi-
cal principles for animal experimentation adopted by the 
Brazilian College of Animal Experimentation, and the 
Animal Experimentation Committee of the University of 
São Paulo at Ribeirão Preto School of Medicine approved 
the study protocol (COBEA/CETEA/FMRP-USP, proto-
col no. 050/2010). The animals were subjected to 5/6 NE 
according to the technique described previously.23 The ani-
mals were anesthetized with 2.5% tribromoethanol solu-
tion in phosphate-buffered solution (PBS) (0.15 mol/l 
NaCl and 0.01 mol/l phosphate buffer, pH=7.4) adminis-
tered intraperitoneally (1 ml/100 g). The right kidney was 
removed, and an infarction was provoked in two-thirds of 
the left kidney by ligation of one or two branches of the 
left renal artery. In the control group, a sham (S) operation 
with manipulation of the renal pedicles without causing 
ischemia or destruction of renal tissue was performed via 
laparotomy. The animals were divided into four groups, 
which received the following treatments beginning 15 
days after surgery: sham group (S) (n=10): untreated ani-
mals that underwent the sham surgery; sham+CP (S+CP) 
(n=9): animals that underwent the sham surgery and were 
treated with CP extract; nephrectomized (NE) (n=11): 5/6 
NE animals that were untreated; and nephrectomized+CP 
(NE+CP) (n=14): 5/6 NE animals that were treated with 
CP extract. After the surgical procedure, all groups were 
followed for a period of 90 days. Body weight (BW) and 
systolic blood pressure (SBP), measured by the tail-cuff 
method (CODA System, Kent Scientific, Torrington, 
Connecticut, USA) were evaluated each month from 15–
90 days after surgery. The animals were placed in meta-
bolic cages for 24 h, and urine samples were collected to 
quantify albumin excretion (AE).
Preparation, standardization and administration 
of CP extract
CP leaves were collected at Ribeirão Preto (–21.167925, 
–47.859927, altitude 546 m), State of São Paulo, Brazil. 
Botanical identification was performed by Gerson O 
Romão of the Herbarium of the Escola Superior de 
Agricultura Luiz de Queiroz of the University of São Paulo 
(ESALQ-USP), where the voucher specimen (ESA120140) 
was deposited. Leaves were washed and then dried in the 
shade for 10 days. The leaves were completely dehydrated 
at 40°C for three days. The dried CP leaves were ground in 
a mill (type Wyllie, Tecnal, Piracicaba, São Paulo, Brazil) 
to obtain the powder that was used to prepare the CP 
extract. The CP extract was prepared at a proportion of 2% 
w/v (weight of vegetable/ volume of distilled water) for 30 
min at 72˚C. The CP extract was then decanted for 10 min, 
vacuum filtered, frozen and lyophilized to determine the 
concentration. The process was repeated throughout the 75 
days of the experiment. The CP extract was administered 
in amber glass drinkers given daily to the animals. Six 
samples in triplicate were lyophilized weekly before and 
during the experiment to verify the concentration of CP 
extract. Based on an evaluation of water consumption of 
the animals over a 24 h period, the CP extract was diluted 
for administration of a dose of 0.6 g/kg. The consumed 
volume (ml) of the extract per box was determined and the 
mean dose was evaluated during the treatment.
Determination of the main compounds of the 
CP extract
The determination of the constituents from CP was per-
formed by Liquid Chromatography-Mass Spectra in 
MicroTOF Ic equipament (Bruker Daltonics). Separation 
was done using RP-amide (Ascentis-Supelco, Sigma-
Aldrich) column (25 cm x 4.6 mm; 5 µM). The samples at 
5 mg/ml were prepared in 0.1% formic acid and 10 µ[ was 
injected into the column with a flow of 1 ml/min. The con-
stituents were eluted by linear gradient from 10 to 35% 
acetonitrile-water containing 0.1% formic acid in 30 min. 
The chromatography was monitored by diode array detec-
tion (DAD) at 280 nm and mass spectra. The constituents 
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were characterized by the retention time (RT), mass spec-
trum and ultraviolet-visible spectrum.
Renal function studies
The albumin in urine samples was quantified by electroim-
munoassay24 and the glomerular filtration rate (GFR) was 
evaluated 90 days after surgery by inulin clearance. The 
rats were anesthetized with sodium thiopental (40 mg/kg, 
intraperitoneally). After tracheostomy, the femoral artery 
and vein were cannulated to collect blood samples and to 
inject fluids, respectively. The ureters were cannulated to 
collect urine. Urine samples were collected before the 
administration of inulin solution to analyze TGF-β and 
MCP-1. After this urine sample collection the rats received 
a priming inulin dose (12 mg/100 g diluted in PBS solu-
tion), followed by a maintenance inulin dose of 0.5 mg/
min/100 g. After 60 min stabilization, urine was collected 
for 1 h, and the blood was sampled at 30 and 60 min. The 
kidneys were perfused through the aorta with PBS solution 
and removed for histological and immunohistochemical 
studies. The animals were killed via anesthesia overdose. 
Inulin was quantified in the plasma and urine samples by 
the method of Führ et al.25 Sodium and potassium were 
measured in the plasma and urine by flame photometry 
(Micronal, model 262, São Paulo, Brazil), and urine osmo-
lality was assessed by freezing point depression using an 
Osmometer (Fiske OS, Norwood, Massachusetts, USA).
Quantification of TGF-β and MCP-1 in urine
The urine samples collected by the ureter were immedi-
ately treated with 1 mM phenylmethylsulfonil fluoride 
(PMSF, Sigma Chemical Co, St. Louis, Missouri, USA) 
and stored at −70ºC until analysis. The TGF-β and MCP-1 
quantification was performed by ELISA using commercial 
kits (Promega Corporation, Madison, Missouri, USA and 
Pierce, Rockford, USA, respectively). The median values 
of TGF-β and MCP-1 in the urine samples are expressed in 
pg of TGF-β or MCP-1 per mg creatinine.
Enzymatic activity assay
ACE catalytic activity was determined fluorimetrically as 
described by Friedland and Silverstein.26 The renal cortex 
tissue was homogenized in borohydrate buffer 100 mM, 
pH 7.2, containing sucrose 340 mM, NaCl 300 mM and 
PMSF 10 mM (1 g tissue: 10 ml buffer). The homogenates 
were centrifuged at 5000 rpm, at 4°C for 10 min and the 
supernatant was frozen at −70oC until analyzed. An aliquot 
of plasma or kidney homogenate (10 µl) was incubated 
with 200 µl assay solution (ZPhe-HisLeu 1 mM, sodium 
borohydride buffer 100 mM, pH 8.3, NaCl 300 mM and 
ZnSO4 0.1 mM) for 10 min at 37°C. The enzymatic reac-
tion was stopped by the addition of 1.5 ml of NaOH 280 
mM. The liberated dipeptide, HL (His-Leu), was measured 
fluorimetrically (360 nm excitation and 465 nm emission) 
using a Tecan Infinit F200 equipment as follows.27 One 
hundred of o-phthaldialdehyde (20 mg/ml) diluted in 
methanol was added and after 10 min the solution was 
acidified with 200 µl 3N HCl and centrifuge at 3000 rpm 
for 10 min at room temperate. The standard curve was 
obtained using varying concentrations of L-HL and it 
showed a linear relation between relative fluorescence and 
HL concentration. All the assays were performed in dupli-
cate. The values median of the ACE activity in the renal 
cortex or plasma are expressed in nmol/mg of protein or 
mU/ml of HL produced, respectively.
Light microscopy
Histological sections (3 µM) were stained with Masson’s 
trichrome for examination under a light microscope. The 
incidence of glomerulosclerosis was determined by scoring 
50 glomeruli within a section of each kidney. The glomeru-
lar sclerosis and tubulointerstitial lesion incidence were 
evaluated by scores that reflected changes in the extent of 
the lesion (0: 0–5%, 1: 5–25%, 2: 25–50%, 3: 50–75%, 4: 
>75%), and mean values per kidney were calculated. The 
fractional interstitial area in the renal cortex was determined 
by morphometry with a light camera connected to analyzer. 
Twenty grid fields (measuring 0.200 mm2) were evaluated 
in the renal cortex of each kidney. Interstitial areas were first 
manually encircled on a video screen and then determined 
by computerized morphometry (Axion version 4.8.3, Zeiss) 
and the mean values per kidney were calculated.
Immunohistochemical analysis
The sections were incubated at 4°C overnight with 1/30 
anti p-JNK monoclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, California, USA), 1/200 anti-
AII polyclonal antibody (Peninsula Laboratories, San 
Carlos, USA), or for 1 h with 1/1000 anti-ED1 monoclonal 
antibody that only reacts with cytoplasmic antigen present 
in macrophages and monocytes (Serotec, Oxford, UK), 
1/500 anti-vimentin and 1/200 anti-desmin monoclonal 
antibodies (Dako, Glostrup, Denmark). The reaction prod-
uct was detected with an avidin-biotin-peroxidase com-
plex (Vector Laboratories, Burlingame, California, USA). 
Negative controls were created by replacing the primary 
antibody with normal mouse immunoglobulin G (IgG) or 
rabbit IgG for monoclonal or polyclonal antibodies, 
respectively, at equivalent concentrations. The color reac-
tion was developed with immunoglobulin G (IgG, Sigma 
Chemical Company, St. Louis, Missouri, USA).
The sections were counterstained with methyl green or 
with Harris hematoxylin, dehydrated and mounted. To eval-
uate the immunoperoxidase staining for p-JNK, vimentin, 
and the cortical glomeruli and tubulointerstitial region were 
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semi-quantitatively graded through examination of 50 glo-
meruli and 30 grid fields (measuring 0.200 mm2), and the 
mean score per kidney was calculated.28 Vimentin was used 
as a marker of tubular cell lesions and was assessed only in 
the tubulointerstitial area.29 Desmin was used as a marker of 
podocyte lesions and was only evaluated at the glomerular 
edge.29 The scores mainly reflected changes in the extent, 
rather than the intensity, of staining and depended on the 
percentage of glomeruli or grid field showing positive stain-
ing: 0: 0–5%, 1: 5–25%, 2: 25–50%, 3: 50–75% and 4: 
>75%.
The number of ED1 (macrophages/monocytes)-posi-
tive cells (glomeruli and renal cortical tubulointerstitium) 
and of AII (cortical tubulointerstitium) were counted 
through the examination of 50 glomeruli and 30 grid fields 
(measuring 0.200 mm2), respectively, and the mean counts 
per kidney were calculated.
Statistical analysis
One way analysis of variance (ANOVA) with the Newman-
Keuls comparison test was used for the data that were nor-
mally distributed (SBP, BW and AII) or that showed a 
normal distribution after log10 transformation (AE, ED1+ 
and TGF-β). Those data are expressed as mean and stand-
ard error of the mean (SEM) or geometric means and con-
fidence intervals, respectively. For data related to other 
studied parameters, we used nonparametric Kruskall-
Wallis test with Dunn’s post-test. Those data are expressed 
as median and interquartile. The Mann-Whitney test was 
performed for analysis of the fractional interstitial area and 
mean consumed dose. Statistical analyses were performed 
using GraphPad Prism version 5.0 for Windows, GraphPad 
Software, San Diego, California, USA. The level of statis-
tical significance was set at p<0.05.
Results
Determination and control of the CP extract 
dose
CP extract dose was determined from a previously pilot 
experiment based on the effect in SBP after 15 days of the 
treatment. The rats consumed a daily dose of approxi-
mately 0.6 g/kg. There was no difference (p>0.05) between 
the mean dose consumed by the groups treated with CP 
extract [S+CP (0.55±0.04 g/kg) and NE+CP (0.63±0.03 g/
kg)] during the 75 days of the treatment.
Determination of the main components of the 
CP extract
Two predominant peaks detected at 280 nm in the 
Liquid Chromatography-Electrospray Ionization-Mass 
Spectrometry (LC-ESI-MS+) analysis of CP extract 
represent the chlorogenic acid and orientin. The pres-
ence of chlorogenic acid was confirmed by comparison 
with a UV/VIS spectrum of the authentic sample. The 
RT (12.5 min) and ESI/MS+ detection (m/z 355) 
matched. Chlorogenic acid was the predominant peak 
in CP extract, followed by orientin. The identity of ori-
entin was confirmed by RT (14.9 min) and the fragmen-
tation patterns in ESI/MS-. It has been shown that 
orientin inhibits ACE in in vitro studies.22
Systolic pressure blood (SBP), body weight and 
albumin excretion (AE)
The 5/6 NE rats showed a significant increase in SBP and 
AE compared to the sham rats. However, the increase in 
SBP was less intense on days 30 and 90 (p<0.01) and in 
AE on days 30 and 60 (p<0.05) in NE+CP rats compared 
to NE rats (Table 1). There was no difference in body 
weight between 5/6 NE groups (Table 1).
Renal function studies
The 5/6 NE rats presented reduction in GFR and increase 
in the sodium and potassium fractional excretion com-
pared to rats from sham groups. Treatment with CP extract 
reduced all these alterations. However, the change in urine 
osmolality was not modified by treatment with CP extract 
(Table 2).
TGF-β and MCP-1 urinary excretion
Increase in the urinary excretion of TGF-β and MCP-1 was 
observed in 5/6 NE rats when compared to sham groups. 
These alterations were attenuated by CP extract treatment 
(Table 3). Data from the S+CP group are not shown.
Enzymatic activity assay
Increase in ACE activity in both renal tissue and plasma 
was observed in 5/6 NE rats when compared to sham 
group. The increased activity in renal tissue was attenuated 
by CP extract treatment (Table 3). There was no significant 
difference in ACE activity between S and S+CP groups 
(data not shown).
Light microscopy
Light microscopy studies of the renal cortex of rats that 
underwent 5/6 NE revealed the following morphological 
features, which are characteristic of this model: glomeru-
losclerosis, tubular lumen dilation with denuded base-
ment membrane, swelling/flattening of proximal tubular 
cells with brush border loss, tubular atrophy, and an 
increase in the interstitial area with inflammatory cell 
infiltrates. These histological changes were less intense in 
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the NE+CP rats (Figure 1(a)–(e)). The score for glomeru-
losclerosis was higher in the NE rats untreated compared 
to NE+CP rats and the fractional relative interstitial area 
was also higher in these rats (p<0.05, NE vs NE+CP) 
(Figure 1(f)).
Immunohistochemical analysis
The expressions of vimentin in the tubulointerstitial area 
and desmin at the glomerular edge were higher in the 
renal cortex of 5/6 NE rats than in sham rats. These 
increases were attenuated in NE rats by treatment with the 
CP extract (Figure 2). The increased p-JNK expression 
and the number of ED1-positive cells in the renal cortex 
tubulointerstitium and glomeruli observed in 5/6 NE rats 
were also lower in NE+CP rats (Figure 3). The number of 
AII positive cells in the tubulointerstitial area from the 
renal cortex was higher in the NE rats compared to the 
sham rats and this increase was less intense in NE+CP 
group (Figure 4).
Discussion
The results of this study show that treatment with CP 
extract reduced the blood pressure and the functional and 
structural renal changes in 5/6 NE rats. These effects were 
associated with the reductions of the number of positive 
cells for AII, as well as the ACE activity in the renal cor-
tex of CP-treated rats. The increase in AII renal content 
could be due to higher plasma levels of AII and/or the 
Table 1. Body weight (BW), systolic blood pressure (SBP) and urinary albumin excretion (AE) in control rats and in rats subjected 
to 5/6 nephrectomy (NE), treated or untreated with Cecropia pachystachya (CP) extract 15 to 90 days after surgery.
Days (d) after surgery
 15 d 30 d 60 d 90 d
BW, g
S 263 ± 21 428 ± 23 500 ± 15 580 ± 20
S+CP 300 ± 4 434 ± 18 558 ± 17 609 ± 22
NE 277 ± 16 390 ± 19 478 ± 29 519 ± 35
NE+CP 269 ± 9 368 ± 18 487 ± 13 530 ± 17
SBP, mm Hg
S 114 ± 5 107 ± 7 126 ± 3 125 ± 2
S+CP 110 ± 7 115 ± 4 128 ± 5 127 ± 4
NE 193 ± 8a,b 206 ± 3a,b 211 ± 9a,b 217 ± 13a,b
NE+CP 178 ± 11a,b 167 ± 11a,b,c 180 ± 5a,b,d 181 ± 11a,b,c
AE, mg/24 h
S 0.2 (0.21; 0.43) 0.18 (0.1; 0.5) 0.1 (0.0; 0.3) 0.3 (0.1; 0.8)
S+CP 0.5 (0.2; 1.2) 0.32 (0.1; 0.6) 0.2 (0.1; 0.4) 0.2 (0.0; 1.7)
NE 24 (6; 91) a,b 60 (12; 301)a,b 93 (40; 318)a,b 166 (80; 344)a,b
NE+CP 15 (6; 29) a,b 13 (5 ; 39)a,b,e 19 (7; 55)a,b,e 63 (18; 210)a,b
S: sham. Data are presented as mean±standard error of the mean (SEM; BW and SBP) or geometric mean and confidence intervals (AE). ap<0.001 vs 
S, bp<0.001 vs S+CP, cp<0.01 vs NE, dp<0.001 vs NE, ep<0.05 vs NE.
Table 2. Urine osmolality (Uosm), sodium and potassium fractional excretions (FENa+ and FEK+), and glomerular filtration rate 
(GFR) in control rats and in rats subjected to 5/6 nephrectomy (NE) treated or untreated with Cecropia pachystachya (CP) extract, 
90 days after the surgery.
Uosm 
(mOsm/Kg H20)
FENa+ 
(%)
FEK+ 
(%)
GFR 
(ml/min/100 g).
S 1769 0.1 15 0.44
 (1625; 2535) (0.1; 0.5) (7; 57) ±0.04
S+CP 959 0.1 12 0.47
 (756; 1129) (0.1; 0.2) (9; 20) ± 0.09
NE 547a,c 1.9b,e 57a,e 0.12c,f
 (482; 671) (0.8; 3.0) (47; 91) ± 0.03
NE+CP 584b 0.3 25 0.27a,d,g
 (528; 995) (0.1; 0.6) (18; 41) ± 0.04
S: sham. Data are presented as median and interquartile range (25%;75%) (Uosm, FENa+ and FEK+) or mean±standard error of the mean (SEM; GFR). 
ap<0.05, bp<0.01, cp<0.001 vs S, dp<0.05, ep<0.01, fp<0.001 vs S+CP, gp<0.05 vs NE.
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enhancement of renal AII production.30,31 AII has an 
important role in the renal lesions observed in 5/6 NE rats. 
In addition to its effect on renal and systemic hemody-
namics, AII also contributes to the inflammation and 
fibrosis observed in this model of chronic kidney disease.4 
The AII effects may be mediated in part by activation of 
TGF-β, NF-κB and JNK pathways.6,7,9,13 In this study we 
also observed that the increased expression of p-JNK in 
the 5/6 NE rats was attenuated by CP extract treatment. 
Activation of the NF-κB and JNK pathways induces 
apoptosis and the synthesis of inflammatory mediators 
(cytokines, growth factors and adhesion molecules as well 
as macrophage and monocyte chemotactic factors), lead-
ing to kidney damage.7,13
The recruitment and activation of macrophages is one 
pathway whereby AII contributed for the impaired func-
tional and structural renal in the 5/6 NE. We observed a 
significant reduction in the number of macrophages in the 
glomeruli and tubulointerstitial area of the renal cortex 
from 5/6 NE rats treated with CP extract. The reduction of 
these inflammatory cells in the renal cortex of the treated 
rats was associated with the reduction of AII and p-JNK 
expressions, and of ACE activity in renal cortex and of the 
urinary levels of TGF-β and MCP-1. Macrophages can 
release cytokines such as interleukin-1, TGF-β and AII, 
which can intensify inflammation and fibrosis observed in 
the kidney from these rats.32 The orientin and chlorogenic 
acid, the main compounds identified in CP extract, are well 
Table 3. Transforming growth factor β (TGF-β) and monocyte chemoattrant protein-1 (MCP-1) urinary excretions and 
angiotensin-converting enzyme (ACE) activity in plasma and renal tissue of rats subjected to 5/6 nephrectomy (NE), treated or 
untreated with Cecropia pachystachya (CP) extract, 90 days after surgery.
TGF-β 
(pg/mg urinary creatinine)
MCP-1 
(pg/mg urinary creatinine)
Renal ACE activity 
(nmol/mg prot)
Plasma ACE activity 
(mU/ml)
S 104 (59–183) 471 (303; 812) 2.2 (0.9; 3.2) 219 (204; 233)
NE 10,121a (2866–35,746) 7511b (4800; 11,024) 3.4b (3.0; 3.7) 407a (332; 436)
NE+CP 1678a,c (732–3844) 2473 (1035; 5644) 1.2d (0.9; 2.3) 356a (301; 403)
S: sham. Data are presented as geometric mean and confidence intervals (TGF-β) or median and interquartile (25%;75%) (MCP-1 and ACE activity). 
ap<0.001 vs S, bp<0.05 vs S, cp<0.01 vs NE, dp<0.001 vs NE.
Figure 1. Representative Masson’s trichrome-stained histological sections from (a) control, (b) 5/6 nephrectomy (NE), and (c) 
NE+Cecropia pachystachya (CP) groups, 90 days after surgery. Note that the glomerular sclerosis and the interstitial lesions in (b) 
are more intense than in (c). Bars indicate 50 µm. Score for (d) tubulointerstitial and (e) glomerular lesions from S (squares), S+CP 
(triangles), NE (inverted triangles), and NE+CP (diamonds) groups, and (f) fractional interstitial area of the rats subjected to 5/6 NE 
(NE and NE+CP), 90 days after surgery. Horizontal lines represent the median in (d) and (e) or mean in (f). **p<0.01, ***p<0.001 vs 
sham (S); #p<0.05, ##p<0.01 vs S+CP; •p<0.05 NE.
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known as potent anti-inflammatory and anti-tumoral 
agents.18,19 It was also shown by in vitro studies that orien-
tin inhibits ACE22 suggesting that the CP extract effects in 
the reduction of the renal injury can be related at least in 
part with the decrease of the AII production in the NE rats.
The reduction of the urinary excretion of TGF-β in the 
NE+CP rats could be contributed with the reduction of 
glomerulosclerosis and the reduction of tubulointerstitial 
lesions in the NE+CP rats. There is evidence that urinary 
TGF-β is derived from renal biosynthesis and not from 
plasma.1,33 In previous clinical and experimental studies 
performed in our laboratory, we observed a correlation 
between the rate of urinary TGF-β excretion and the inci-
dence of glomerular sclerosis and tubule interstitial 
lesions.1,34 Together, TGF-β and AII can induce pheno-
typic modification in cells, causing them to express α-
smooth muscle actin and increase the production of 
collagen and other ECM components, which was evi-
denced by the higher fractional interstitial area in renal 
cortex from NE compared to NE+CP rats.
CP extract treatment also attenuated the podocyte 
lesions in the NE rats and this was evidenced by reduction 
of desmin expression at the glomerular edge, a sensitive 
marker of podocyte lesions.29 The reduction in podocyte 
damage in the NE+CP rats can explain the decreased albu-
minuria in these animals until 60 days after surgery. There 
is a correlation between urinary protein levels and the rate 
of renal function decline in patients with glomerulonephri-
tis.35,36 The albumin handling by cells of the proximal 
tubule can also stimulate their production of pro-inflam-
matory cytokines.7 There was a reduction in the tubuloint-
erstitial lesions in the 5/6 NE rats treated with CP extract 
evidenced by reduced expression of vimentin, and of the 
relative interstitial area. Vimentin is expressed in the 
Figure 2. Representative immunostaining for (a)–(c) vimentin and (d)–(f) desmin from (a), (d) control, (b), (e) 5/6 nephrectomy 
(NE) and (c), (f) NE+ Cecropia pachystachya (CP) groups, respectively, 90 days after surgery. Note that the expression of vimentin 
in the tubular cells and of desmin at glomerular edge are higher in (b) and (e) than in (c) and (f), respectively. Bars indicate 50 µm. 
Scores for (g) vimentin in the renal cortical tubulointerstitium per area of renal cortex measuring 0.200 mm2 and for (h) desmin at 
glomerular edge in control rats (sham (S) and S+CP) and rats subjected to 5/6 NE, treated or untreated with CP extract (NE and 
NE+CP), 90 days after surgery. Horizontal lines represent the median. **p<0.01, ***p<0.001 vs S; #p<0.05, ##p<0.01, ###p <0.001 vs 
S+CP.
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Figure 3. Representative immunostaining for (a)–(c) p-JNK and (d)–(f) ED1-positive cells (macrophages) from Control (a), (d), NE 
(b), (e), and NE+CP (c), (f) groups, 90 days after surgery. Note that the expression of p-JNK and the number of ED1-positive cells in 
the tubular cells and glomerulus are higher in (b) and (e) than in (c) and (f). Bars indicate 50 µm. Scores for p-JNK (g), (h) and number 
of ED1-positive cells (i) and (j) in the renal cortex tubulointerstitium (g), (i) and glomerulus (h), (j), in control rats (sham (S)) and 
rats subjected to 5/6 NE (NE and NE+CP), treated or untreated with CP extract, 90 days after surgery. Horizontal lines represent 
median (g), (h) and bars represent geometric mean (i), (j)). *p<0.05, **p<0.01, ***p<0.001 vs S; ##p<0.01, ###p<0.001 vs S+CP.
Figure 4. Representative immunostaining for angiotensin II (AII) (arrows) from (a) control, (b) nephrectomy (NE), and (c) NE+CP 
(Cecropia pachystachya) groups, 90 days after surgery. Note that the expression of AII is higher in (b) than in (c). Bars indicate 50 
µm. Number of AII-positive cells (d) in the renal tubulointerstitium per area of renal cortex measuring 0.200 mm2 in control rats (S) 
and rats subjected to 5/6 NE (NE and NE+CP), treated or untreated with CP extract, 90 days after surgery. The data are expressed 
as the mean±standard error of the mean (SEM). S: sham. ***p<0.001 vs S; ##p<0.01 vs S+CP; ••p<0.01 NE.
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tubular cells only when they are proliferating.29 The 
improvement of the tubular injury was associated with the 
decrease in sodium and potassium fractional excretion in 
the NE+CP rats.
In conclusion, the treatment with CP extract reduced 
the SBP and functional and structural renal changes in the 
rats submitted to 5/6 NE. These effects were associated 
with the decrease of macrophage infiltration, ACE activity 
and AII expression in the renal cortex of NE+CP rats. The 
reduction of macrophages and AII in the renal cortex of the 
rats treated with CP extract, can be explained, at least in 
part, by the ACE inhibition by some components of CP 
extract such as orientin. Renal and plasma ACE activity 
was increased in NE rats compared to S rats, but decreased 
in the NE+CP group suggesting an ACE inhibition by CP 
extract. Renal ACE activity was inhibited in 67% of NE 
rats by treatment with CP extract, differing from plasma 
ACE that was inhibited in around 12.5%. However, tissue 
AII generation by ACE does not run in parallel with AII 
generation in the circulation. These results showed that in 
5/6 NE rats the decrease of renal injury and hypertension 
by CP extract was more related to renal than to plasma 
ACE inhibition. However, further research is required to 
test the ACE inhibitory activity in vivo of isolated compo-
nents of CP extract.
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